ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

Cancer Act 25th Year: cancer Mortality Rate Began decline In 1990s, NCI, ACS Studies Find

November 22, 1996

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980